retatrutide phase 2 obesity trial results just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a study: • Up to 24.2% mean weight loss at 48 weeks retatrutide trials results 🚨 BREAKING:

Keys, A.J., Wiener, D.J., Pacini, S.M., Sun, C.Z., Sandusky, L.E., Zhong, H.Y

Consult an expert before using supplements in case of pregnancy, lactation, medication use and illness

Typical dosing starts low and increases every 4 weeks until the maintenance dose

Evidence for continued use The degree of benefit reported in the study is very close to that seen in a different trial, called the SELECT study, which looked at the reduction in heart events in people taking semaglutide for obesity

Red flags: when to call a clinician and when to seek urgent care The vast majority of people on GLP-1 therapy do not experience serious complications